Pricing

Trump Announces 100% US Pharma Tariffs for Patented Drugs

Yuvraj — Sat, 04 Apr 2026 08:55:16 +0000

The US pharma tariffs policy has been formalised through an executive order signed by Donald Trump, introducing tariffs of up to 100% on imported branded medicines. The measure targets pharmaceutical companies that have not entered into drug pricing agreements with the US government or committed to establishing manufacturing operations domestically. Positioned as a national security […]

The post Trump Announces 100% US Pharma Tariffs for Patented Drugs first appeared on World Pharma Today.

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

Yuvraj — Tue, 03 Mar 2026 13:10:36 +0000

The Centers for Medicare & Medicaid Services (CMS) in the US has moved to extend the enrolment window for its GENEROUS pilot programme, an initiative aimed at introducing most-favoured-nation (MFN) pricing for outpatient drugs reimbursed by Medicaid. The agency has revised the participation deadline, shifting it from the end of this month to 30th April. […]

The post CMS Extends GENEROUS MFN Drug Pricing Deadline to April first appeared on World Pharma Today.

CMS Unveils a New Voluntary Access Programme For GLP-1

Yuvraj — Fri, 02 Jan 2026 13:01:53 +0000

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new voluntary access programme which aims to widen the usage of GLP-1 agonist medicines when it comes to diabetes as well as obesity via Medicare and Medicaid. Notably, the Better Approaches to […]

The post CMS Unveils a New Voluntary Access Programme For GLP-1 first appeared on World Pharma Today.

Novartis to Lower Innovative Medicines Price in the US

Yuvraj — Fri, 26 Dec 2025 06:57:43 +0000

Novartis, which is a leading global innovative medicines company, went ahead and announced on December 19, 2025, that it has reached an agreement along with the US government that aims to lower innovative medicines price in the US and also support the ongoing US investment when it comes to manufacturing, research, and development. Apparently, Novartis has voluntarily […]

The post Novartis to Lower Innovative Medicines Price in the US first appeared on World Pharma Today.

New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices

Yuvraj — Fri, 26 Dec 2025 06:52:11 +0000

President Donald Trump on December 19, 2025, said that his administration has reached agreements with nine additional pharmaceutical companies, therefore extending a campaign that is aimed at decreasing the prescription drug prices for certain Americans while at the same time, temporarily shelving the threatened import tariffs. Notably, these latest agreements bring the total to 14 […]

The post New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices first appeared on World Pharma Today.

Trump To Exempt UK-Origin Pharmaceuticals from Tariffs

Yuvraj — Fri, 05 Dec 2025 07:27:41 +0000

The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers the biggest break on pharmaceutical import tariffs yet with Washington. For its part, the U.K., which has indeed faced tough policy scrutiny from the biopharma industry in the recent months, is […]

The post Trump To Exempt UK-Origin Pharmaceuticals from Tariffs first appeared on World Pharma Today.

FDA Looks to Accelerate Biosimilar Drug Development

Yuvraj — Tue, 25 Nov 2025 13:33:37 +0000

The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower the cost pertaining to biosimilar agents when it comes to cancer as well as any other serious illnesses. These policies go on to include major updates so as to simplify the biosimilarity […]

The post FDA Looks to Accelerate Biosimilar Drug Development first appeared on World Pharma Today.

Clinical Trial Supplies Market Worth $8.18 Billion by 2030

Yuvraj — Fri, 04 Jul 2025 07:10:56 +0000

The market for clinical trial supplies is about to change a lot because there is a growing need for new ways to help people with their health and because medical research is making progress. As the world changes, the clinical trials market is anticipated to reach USD 8.18 billion in 2030 from USD 5.34 billion […]

The post Clinical Trial Supplies Market Worth $8.18 Billion by 2030 first appeared on World Pharma Today.